EMILY HOGAN: Open Payments
NPI 1144580804 · GLEN ALLEN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 35 payments from 12 companies in 2025. Trend: 2023 $1,511 · 2024 $1,112 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $146 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $114 |
| Incyte Corporation | 4 | $111 |
| UCB, Inc. | 4 | $88 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Arcutis Biotherapeutics, Inc. | 4 | $80 |
| Organon LLC | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Galderma Laboratories, L.P. | 2 | $29 |
| ABBVIE INC. | 1 | $26 |
Products named: OTEZLA, OPZELURA, ILUMYA, Bimzelx, COSENTYX, Zoryve, VTAMA, DUPIXENT.
Industry payments across VA — which companies pay providers there.
